Vaxxinity Inc - Ordinary Shares - Class A

NASDAQ:VAXX  
4.40
+0.31 (+7.58%)
Earnings Announcements

Vaxxinity Reports Fourth Quarter And Full-Year 2021 Financial Results And Provides Corporate Updates

Published: 03/24/2022 20:54 GMT
Vaxxinity Inc - Ordinary Shares - Class A (VAXX) - Vaxxinity Reports Fourth Quarter and Full-year 2021 Financial Results and Provides Corporate Updates.
Q4 Loss per Share $0.48.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.